garenoxacin has been researched along with Sensitivity and Specificity in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frisbee-Hume, S; Ho, DH; LeBlanc, BM; Rolston, KV; Streeter, H | 1 |
Biedenbach, DJ; Jones, RN | 1 |
Anderegg, TR; Biedenbach, DJ; Jones, RN | 1 |
Bello, A; Gajjar, DA; Grasela, DM; Meurling, L; Nord, CE; Russo, RL | 1 |
Cavazos-Rocha, N; de la Luz Salazar-Cavazos, M; Vera-Cabrera, L; Waksman-de-Torres, N; Welsh-Lozano, O | 1 |
Nicolau, DP; Nightingale, CH; Turley, C; Xuan, D | 1 |
Barrett, JF; Frosco, M; Ho, H; Lawrence, LE; Mazzucco, CE; Ryan, BM; Warr, G | 1 |
1 trial(s) available for garenoxacin and Sensitivity and Specificity
Article | Year |
---|---|
Effect of garenoxacin on eubacteria in the normal intestinal microflora when administered concomitantly with digoxin.
Topics: Administration, Oral; Adolescent; Biological Availability; Colony Count, Microbial; Digoxin; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Eubacterium; Feces; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Indoles; Intestinal Mucosa; Male; Microbial Sensitivity Tests; Prospective Studies; Quinolones; Sensitivity and Specificity | 2003 |
6 other study(ies) available for garenoxacin and Sensitivity and Specificity
Article | Year |
---|---|
Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Indoles; Levofloxacin; Male; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Sensitivity and Specificity | 2002 |
Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001).
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Microbial; Female; Fluoroquinolones; Haemophilus influenzae; Humans; Indoles; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; North America; Quinolones; Respiratory Tract Infections; Sensitivity and Specificity; Streptococcus pneumoniae | 2003 |
Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Guidelines as Topic; Haemophilus influenzae; Humans; Indoles; Microbial Sensitivity Tests; Quality Control; Quinolones; Sensitivity and Specificity; Streptococcus pneumoniae | 2003 |
Simultaneous determination and validation of antimicrobials in plasma and tissue of actinomycetoma by high-performance liquid chromatography with diode array and fluorescence detection.
Topics: Acetamides; Acetonitriles; Amoxicillin; Animals; Anti-Bacterial Agents; Buffers; Chemical Precipitation; Chromatography, High Pressure Liquid; Drug Stability; Fluoroquinolones; Freezing; Hydrogen-Ion Concentration; Linezolid; Mice; Mycetoma; Oxazolidinones; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Sulfamethoxazole; Time Factors; Trimethoprim; Water | 2007 |
Determination of BMS-284756, a new quinolone, in mouse serum by high-performance liquid chromatography with fluorescence detection.
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Indoles; Mice; Quinolones; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2001 |
Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Blood Bactericidal Activity; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Indoles; Levofloxacin; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Sensitivity and Specificity; Staphylococcus aureus | 2002 |